Prof. Dr. Selman Fatih BEŞIŞIK

Yayın Ağı

Makaleler 147

1. Extra intestinal manifestations may increase the risk of synchronous and metachronous development of other extraintestinal manifestations in patients with Crohn’s disease

Ozkahraman A., Kayar Y., Dertli R., Konur S., Kılıc G., Baran B., et al.

Scientific Reports , cilt.15, sa.1, 2025 (SCI-Expanded)

2. A prospective study on the role of non-invasive tests in the evaluation of diabetes mellitus associated steatotic liver disease

İstemihan Z., Bektaş F., Bardak A. E., Kızıltaş C., Kemeç G., İmanov Z., et al.

Scientific Reports , cilt.15, sa.1, 2025 (SCI-Expanded)

3. Real World Efficacy and Safety of Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Liver Transplant Recipients

Bektas E., Yilmaz A., Kikili C. I., Nuriyev K., Istemihan Z., Senkal I. V., et al.

Transplant Infectious Disease , cilt.27, sa.5, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma

4. USTEKINUMAB EFFECTIVENESS AND SUSTAINABILITY IN ULCERATIVE COLITIS AND CROHN’S DISEASE

İstemihan Z., Teberik Kama E., Altın S., İmanov Z., Şenkal İ. V., Nurıyev K., et al.

Journal of İstanbul Faculty of Medicine , sa.88, ss.256-263, 2025 (Hakemli Dergi)

5. The role of GALAD score in the surveillance of hepatocellular carcinoma.

İstemihan Z., Şenkal İ. V., Karaca D., Nurıyev K., Rustamzade A., Genç Uluçeçen S., et al.

Scientific reports , cilt.15, sa.1, ss.22279, 2025 (SCI-Expanded)

6. Anxiety and Depression Outcomes in Liver Transplant Candidates and Recipients Using the Hospital Anxiety and Depression Scale

Bardak A. E., Cifcibasi Ormeci A., Yildiz Z., Senkal V., Imanov Z., Istemihan Z., et al.

Transplantation Proceedings , cilt.57, sa.6, ss.1170-1175, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma

7. The Role of Pancreatic Enzyme Insufficiency in the Etiology of Functional Dyspepsia Resistant to Standard Treatment

kemik f., CEYLAN G., Aydın A. F., Çavuş B., Ormeci A., Imanov Z., et al.

Turkish Journal of Gastroenterology , cilt.36, sa.7, ss.467-473, 2025 (SCI-Expanded)

8. Results in chronic hepatitis B patients using tenofovir and entecavir for at least 10 years; HBV clearance rare, disease outcomes good: An observational cohort study

Istemihan Z., Kemeç G., Cebeci T., Çetin O., Uluçeçen S. G., Rüstemzade A., et al.

Medicine (United States) , cilt.104, sa.23, 2025 (SCI-Expanded)

9. Inflammation and Immune-Based Scores Predict Prognosis for Patients with Hepatocellular Carcinoma: A Pilot Single-Center Study

Dirim M. G., Ormeci A. C., Cavus B., Poyanli A., Serin K. R., Akyuz F., et al.

Turkish Journal of Gastroenterology , cilt.36, sa.4, ss.219-228, 2025 (SCI-Expanded)

10. What are the predictors of malignancy in inflammatory bowel disease?

İstemihan Z., Çavuş B., Bardak A. E., Kirkoğlu A. M., Kiziltaş C., Silay R., et al.

Turkish Journal of Medical Sciences , cilt.55, sa.4, ss.846-854, 2025 (SCI-Expanded)

11. Virological and Biochemical Effects of Tenofovir Alafenamide in Different Patient Groups With Chronic Hepatitis B Virus Infection in Real-World Cohort

Bektas E., Yilmaz A., Kikili C. I., Nuriyev K., Istemihan Z., Senkal I. V., et al.

International Journal of Hepatology , cilt.2025, sa.1, 2025 (ESCI)

12. Aceruloplasminemia as a rare hereditary disease: four case reports in a single center

İstemihan Z., İmanov Z., Çavuş B., Çifcibaşı Örmeci A., Akyüz F., Beşışık S. F., et al.

Baylor University Medical Center Proceedings , sa.0, ss.1-4, 2024 (Scopus)

13. Inflammatory Bowel Disease and malignancy: What are the predictors of malignancy in Inflammatory Bowel Disease?

Istemihan Z., Cavus B., Bardak A. E., Kirkoglu A. M., Kiziltas C., Silay R., et al.

JOURNAL OF CROHNS & COLITIS , ss.456, 2023 (SCI-Expanded)

14. Is the Y90-radioembolization treatment effective on the intermediate-advanced stage of hepatocellular carcinoma and what is the albumin-bilirubin score’s prediction factor for survival?

Evirgen S., ÇAVUŞ B., Gokturk S., Iliaz R., ÖZKAN Z. G., Baran B., et al.

Hepatology Forum , cilt.4, sa.3, ss.103-107, 2023 (Scopus)

15. Different Faces of Eosinophilic Infiltration of Gastrointestinal System

İSTEMİHAN Z., ÇAVUŞ B., BERKER N., Nuriyev K., Şenkal V., İmanov Z., et al.

Journal of Enterocolitis , cilt.1, sa.3, ss.68-71, 2022 (Hakemli Dergi)

16. Mucocutaneous Manifestations and Associated Factors in Patients with Crohn's Disease

Kayar Y., Dertli R., Konür Ş., Ağın M., Al Kafee A., Baran B., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.33, sa.11, ss.945-954, 2022 (SCI-Expanded)

17. SINGLE CENTER EXPERIENCE OF WILSON DISEASE

Demir K., Ormeci A. C., Cavus B., Akyuz F., Besisik F., Kaymakoglu S.

HEPATOLOGY , cilt.76, 2022 (SCI-Expanded)

18. Cell-free methylation of RASSF1 and CDKN2AIP genes in the diagnosis of hepatocellular carcinoma associated with hepatitis B virus cirrhosis

Telli P., Ozturk N. B., Hakan M. T., Cavus B., Ormeci A. C., Yakut A., et al.

HEPATOLOGY FORUM , cilt.3, sa.3, ss.77-81, 2022 (ESCI) Sürdürülebilir Kalkınma

19. Is anterior segment OCT superior to slit-lamp biomicroscopic examination for Kayser Flesicher ring in Wilson's disease?

Ormeci A., Bayraktar S., Isik A. O., Cavus B., Akas R., Istemihan Z., et al.

European review for medical and pharmacological sciences , cilt.26, sa.14, ss.5178-5185, 2022 (SCI-Expanded)

20. Cyclosporine Therapy as a Rescue Treatment in Steroid Refractory Acute Severe Ulcerative Colitis: A Real Life Data From a Tertiary Center

Evirgen S., Iliaz R., Akyuz F., Cavus B., Gokturk S., Ormeci A., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.33, sa.6, ss.463-469, 2022 (SCI-Expanded)

21. Are Hepatobiliary Manifestations Related to the Site of Involvement in Inflammatory Bowel Disease?

İstemihan Z., Çifcibaşı Örmeci A., Çavuş B., Şenkal İ. V., İmanov Z., Nuriyev K., et al.

Journal of Enterocolitis , cilt.1, ss.12-16, 2022 (Hakemli Dergi)

22. Is there any predictor for relapse after treatment withdrawal in autoimmune hepatitis patients in the real life?

Cavus B., Akyuz F., Iliaz R., Atasoy A., Akyuz U., Demir K., et al.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY , cilt.36, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

23. EVALUATION OF HELICOBACTER PYLORI FREQUENCY AND GASTRIC ANTRUM PATHOLOGY FINDINGS IN PATIENTS WITH PORTAL HYPERTENSION

Cavus B., Ormeci A., Evirgen S., Iliaz R., Atasoy A., Yegen G., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.85, sa.2, ss.211-215, 2022 (ESCI)

24. Prevalence and Association of Restless Leg Syndrome, Depression and Anxiety in Patients With Inflammatory Bowel Disease

Iliaz R., Ozturk N. B., Kilicarslan A. F., Akas R., Guzey D. Y., Senel E., et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY , cilt.116, 2021 (SCI-Expanded)

25. The development of extraintestinal manifestation and related risk factors in Crohn's patients

Kayar Y., Dertli R., Konur S., Agin M., Baran B., Ormeci A., et al.

IRISH JOURNAL OF MEDICAL SCIENCE , cilt.190, sa.2, ss.597-604, 2021 (SCI-Expanded)

26. Gastroesophageal Reflux in Asymptomatic Patients with Diabetes: An Impedance Study Diabetes, Obesity and Gastroesophageal Reflux

Gokturk S., Akyuz F., Arici S., Alpaslan B., Ormeci A., Soyer O. M., et al.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , cilt.128, sa.1, ss.52-58, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

27. Efficacy of adalimumab in mild-to-moderate inflammatory bowel disease: Real-life data from single-centre experience in the long-term period

Akyuz F., Ormeci A., Namazova N., Guzel M., Abbasgoulizadeh A., Tahincioglu L., et al.

JOURNAL OF CROHNS & COLITIS , 2020 (SCI-Expanded)

28. Changing epidemiology of chronic hepatitis C: patients are older and at a more advanced stage at the time of diagnosis

Iliaz R., Yuce T., Torun S., Cavus B., Gulluoglu M., Bozaci M., et al.

European journal of gastroenterology & hepatology , cilt.31, sa.10, ss.1247-1249, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

29. Risk factors associated with progression to intestinal complications of Crohn disease

Kayar Y., Baran B., Ormeci A., Akyuz F., Demir K., Besisik F., et al.

CHINESE MEDICAL JOURNAL , cilt.132, sa.20, ss.2423-2429, 2019 (SCI-Expanded)

30. Cryptogenic liver cirrhosis and hepatitis E virus (HEV): Are they related?

Akyuz F., Cavus B., Pinarbasi B., Bozaci M., Baran B., Akyuz U., et al.

Annals of Hepatology , cilt.18, sa.4, ss.585-589, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

31. Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?

Akyuz F., Cavus B., Iliaz R., Soyer O. M., Ormeci A., Evirgen S., et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.31, sa.7, ss.777-780, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

32. Should we worry about incidental gastrointestinal tract involvement in positron emission tomography/computed tomography as gastroenterologist?

Iliaz R., Cavus B., Yegen G., Alcin G., Gulluoglu M., Karaca C., et al.

Acta gastro-enterologica Belgica , cilt.81, sa.4, ss.471-475, 2018 (SCI-Expanded)

33. Current state and clinical outcome in Turkish patients with hepatocellular carcinoma

Ekinci O., Baran B., Ormeci A., Soyer O. M., Gokturk S., Evirgen S., et al.

WORLD JOURNAL OF HEPATOLOGY , cilt.10, sa.1, ss.51-61, 2018 (ESCI)

34. Predicting mortality in patients with spontaneous bacterial peritonitis using routine inflammatory and biochemical markers

Iliaz R., Ozpolat T., Baran B., Demir K., Kaymakoglu S., Besisik F., et al.

European Journal of Gastroenterology and Hepatology , cilt.30, sa.7, ss.786-791, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

35. NON-ALCOHOLIC HEPATIC STEATOSIS AND LIVER FEATURES AMONG PATIENTS WITH CHRONIC HEPATITIS B

Ozturk N. B., Ozkan E. Y., Avci M., Iliaz R., Atasoy A., Akyuz F., et al.

ALCOHOL AND ALCOHOLISM , 2017 (SCI-Expanded)

36. Belching in irritable bowel syndrome: An impedance study

Obekli T., Akyuz F., Akyuz U., Arici S., Iliaz R., Gokturk S., et al.

Journal of Neurogastroenterology and Motility , cilt.23, sa.3, ss.409-414, 2017 (SCI-Expanded)

37. Analysis of hepatitis C virus NS5A region in patients with cirrhosis using an ultra-deep pyrosequencing method

Keskin F., Ciftci S., Akyuz F., Abaci N., Cakiris A., Akyuz U., et al.

Clinical Laboratory , cilt.63, sa.9, ss.1439-1445, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

38. Role of several cytokines and adhesion molecules in the diagnosis and prediction of survival of hepatocellular carcinoma

Iliaz R., Akyuz U., Tekin D., Serilmez M., Evirgen S., Cavus B., et al.

Arab Journal of Gastroenterology , cilt.17, sa.4, ss.164-167, 2016 (SCI-Expanded, Scopus)

39. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels

Ormeci A., Aydın Y., Sumnu A., Baran B., Soyer O. M., Pinarbasi B., et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , cilt.52, ss.68-73, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

40. A Cross-sectional Study to Assess the Prevalence of Pancreatic Exocrine Insufficiency Among Diabetes Mellitus Patients in Turkey.

Demir K., Karaca C., AHISHALI E., Mestanzade M., Celik S., Gul N., et al.

Pancreas , cilt.45, sa.7, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

41. Diffuse Cavernous Hemangioma of the Colon

Mirioglu Ş., Cavus B., Iliaz R., Besisik F.

ACTA GASTRO-ENTEROLOGICA BELGICA , sa.3, ss.393-394, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

42. Does gastroesophageal reflux increase chronic obstructive pulmonary disease exacerbations?

Iliaz S., Iliaz R., Onur S. T., Arici S., Akyuz U., Karaca C., et al.

Respiratory Medicine , cilt.115, ss.20-25, 2016 (SCI-Expanded)

43. Can Helicobacter pylori be eradicated with high-dose proton pump inhibitor in extensive metabolizers with the CYP2C19 genotypic polymorphism?

ORMECI A., Emrence Z., BARAN B., SOYER O., GOKTURK S., EVIRGEN S., et al.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , cilt.20, sa.9, ss.1795-1797, 2016 (SCI-Expanded)

44. Cyclosporine therapy is effective in acute severe steroid-refractory ulcerative colitis

Iliaz R., Evirgen S., Akyuz F., Cavus B., Pinarbasi B., Karaca C., et al.

JOURNAL OF CROHNS & COLITIS , 2016 (SCI-Expanded)

45. Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole

Ormeci A., Emrence Z., Baran B., Gokturk S., Soyer O. M., Evirgen S., et al.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , cilt.20, sa.5, ss.879-885, 2016 (SCI-Expanded)

46. Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection

Ormeci A., Akyuz F., BARAN B., SOYER O., GÖKTÜRK S., ONEL M., et al.

European Review for Medical and Pharmacological Sciences , cilt.20, sa.5, ss.858-865, 2016 (SCI-Expanded)

47. Tenofovir disoproxil fumarate has a substantial efficacy against multidrug-resistant strains of hepatitis B virus

Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.

LIVER INTERNATIONAL , cilt.35, sa.10, ss.2265-2274, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

48. Isoniazid prophylaxis may not prevent tuberculosis reactivation during anti-TNF treatment

Akyuz F., Iliaz R., Evirgen S., Onder S. Y., Koksalan K., Karaca C., et al.

JOURNAL OF CROHNS & COLITIS , 2015 (SCI-Expanded)

49. Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B

Koklu S., Gulsen M. T., Tuna Y., Koklu H., Yuksel O., Demir M., et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS , cilt.41, sa.3, ss.310-319, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

50. Acute severe hepatitis and hemophagocytosis in adult onset Still’s disease

Sahutoglu T., Kara E., Dogan I. O., Gulluoglu M., Akyuz F., Besisik F.

Archives of Iranian Medicine , cilt.18, sa.10, ss.724-728, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

51. Small bowel mucosal damage in familial Mediterranean fever: results of capsule endoscopy screening

Demir A., Akyuz F., Gokturk S., Evirgen S., Akyuz U., Ormeci A., et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY , cilt.49, sa.12, ss.1414-1418, 2014 (SCI-Expanded)

52. Effects of Polymorphisms in Interferon lambda 3 (Interleukin 28B) on Sustained Virologic Response to Therapy in Patients With Chronic Hepatitis D Virus Infection

Yilmaz E., Baran B., Soyer O. M., Onel M., Onel D., Ormeci A., et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , cilt.12, sa.10, ss.1753-1758, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

53. Esophageal dysmotility: think about in diabetes mellitus patients

Gokturk S., Akyuz U., Akyuz F., Gul N., Iliaz R., Karaca C., et al.

NEUROGASTROENTEROLOGY AND MOTILITY , ss.64, 2014 (SCI-Expanded)

54. Irritable bowel syndrome may overlap the other digestive symptoms

Akyuz F., Obekli T., Akyuz U., Iliaz I., Gokturk S., Evirgen S., et al.

NEUROGASTROENTEROLOGY AND MOTILITY , ss.72, 2014 (SCI-Expanded)

55. Infliximab in inflammatory bowel disease: attention to adverse events

Uyanikoglu A., Ermis F., Akyuz F., Pinarbasi B., Baran B., Aydogan T., et al.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , cilt.18, sa.16, ss.2337-2342, 2014 (SCI-Expanded)

56. Treatment failure may lead to accelerated fibrosis progression in patients with chronic hepatitis C

Baran B., Gulluoglu M., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., et al.

JOURNAL OF VIRAL HEPATITIS , cilt.21, sa.2, ss.111-120, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

57. Durability of sustained virologic response in chronic hepatitis C

UYANIKOĞLU A., Kaymakoglu S., Danalioglu A., Akyuz F., Ermis F., Pinarbasi B., et al.

Gut and Liver , cilt.7, sa.4, ss.458-461, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

58. Efficacy of Tenofovir in Patients with Lamivudine Failure Is Not Different from That in Nucleoside/Nucleotide Analogue-Naive Patients with Chronic Hepatitis B

Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Bozbey H. U., et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , cilt.57, sa.4, ss.1790-1796, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

59. Association of the MEFV Gene Variations With Inflammatory Bowel Disease in Turkey

Akyuz F., Besisik F., Ustek D., Ekmekci C., Uyar A., Pinarbasi B., et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY , cilt.47, sa.3, 2013 (SCI-Expanded)

60. Efficacy of pegylated interferon-alpha treatment for 24 months in chronic delta hepatitis and predictors of response

Karaca C., Soyer O. M., Baran B., Ormeci A., Gokturk S., Aydin E., et al.

ANTIVIRAL THERAPY , cilt.18, sa.4, ss.561-566, 2013 (SCI-Expanded)

61. Measurement of the coronary flow velocity reserve in patients with non-alcoholic fatty liver disease

Pinarbasi B., Demir K., Oflaz H., Ahishali E., Akyuz F., Elitok A., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.23, sa.6, ss.720-726, 2012 (SCI-Expanded)

62. Massive ascites as the initial manifestation of mantle cell lymphoma: A challenge for the gastroenterologist

Yonal I., Ciftcibasi A., Gokturk S., Yenerel M. N., Akyuz F., Karaca C., et al.

Case Reports in Gastroenterology , cilt.6, sa.3, ss.803-809, 2012 (Scopus)

63. A novel two bases deletion in the albumin gene causes analbuminaemia in a young Turkish man.

CARIDI G., DAGNINO M., Di D., AKYÜZ F., BOZTAS G., BESISIK F., et al.

Clinica chimica acta; international journal of clinical chemistry , cilt.413, sa.9-10, ss.950-1, 2012 (SCI-Expanded)

64. Etiological factors of duodenal and gastric ulcers

Uyanikoglu A., Danalioglu A., Akyuz F., Ermis F., Gulluoglu M., Kapran Y., et al.

Turkish Journal of Gastroenterology , cilt.23, sa.2, ss.99-103, 2012 (SCI-Expanded)

65. Acute pancreatitis associated with H1N1 influenza during 2009 pandemic: A case report

Baran B., Karaca C., Soyer O. M., Lacin S., Demir K., Besisik F., et al.

Clinics and Research in Hepatology and Gastroenterology , cilt.36, sa.4, 2012 (SCI-Expanded)

66. Anticoagulant therapy and Budd-Chiari syndrome: Is it successful?

Akyuz F., Cakaloglu Y., Pinarbasi B., Demir K., Akyuz U., Ozdil S., et al.

Hepato-Gastroenterology , cilt.58, ss.900-903, 2011 (SCI-Expanded)

67. Low-Dose Peginterferon Alfa-2a Is Safe and Produces a Sustained Virologic Response in Patients With Chronic Hepatitis C and End-Stage Renal Disease

Peck-Radosavljevic M., Boletis J., Besisik F., Ferraz M. L., Alric L., Samuel D., et al.

Clinical Gastroenterology and Hepatology , cilt.9, sa.3, ss.242-248, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

68. Effect of proton pump inhibitor (PPI) treatment in obstructive sleep apnea syndrome: An esophageal impedance-pHmetry study

Ermis F., Akyuz F., Arici S., Uyanikoglu A., Yakar F., Pinarbasi B., et al.

Hepato-Gastroenterology , cilt.58, ss.1566-1573, 2011 (SCI-Expanded)

69. Is portal hypertensive enteropathy an important additional cause of blood loss in portal hypertensive patients?

Akyuz F., Pinarbasi B., Ermis F., Uyanikoglu A., Demir K., Ozdil S., et al.

Scandinavian Journal of Gastroenterology , cilt.45, sa.12, ss.1497-1502, 2010 (SCI-Expanded)

70. Decreased prohepcidin levels in patients with HBV-related liver disease: relation with ferritin levels.

Yonal O., Akyuz F., Demir K., Ciftci S., Keskin F., Pinarbasi B., et al.

Digestive diseases and sciences , cilt.55, sa.12, ss.3548-51, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

71. Electron microscopic findings in non-alcoholic fatty liver disease: Is there a difference between hepatosteatosis and steatohepatitis?

Ahishali E., Demir K., Ahishali B., Akyuz F., Pinarbasi B., Poturoglu S., et al.

Journal of Gastroenterology and Hepatology (Australia) , cilt.25, sa.3, ss.619-626, 2010 (SCI-Expanded)

72. Autoimmune hepatitis complicated by pyomyositis

Sen F. K., Namli S., Vatansever S., Akkaya V., Erk O., Besisik F., et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.64, sa.1, ss.109-111, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

73. The quality of life in hemodialysis patients with chronic hepatitis C virus infection

Akyuz F., Besisik F., Pinarbasi B., Demir K., Kaymakoglu S., Cakaloglu Y., et al.

Turkish Journal of Gastroenterology , cilt.20, sa.4, ss.243-246, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

74. Are acquired hepatocerebral degeneration and hepatic myelopathy reversible?

Pinarbasi B., Kalymakoglu S., Matur Z., Akyuz F., Demir K., Besisik F., et al.

Journal of clinical gastroenterology , cilt.43, sa.2, ss.176-81, 2009 (SCI-Expanded)

75. Prevalence and virological features of occult hepatitis B virus infection in female sex workers who work uncontrolled in Turkey.

Pinarbasi B., Onel D., Cosan F., Akyuz F., Dirlik N., Cakaloglu Y., et al.

Liver international : official journal of the International Association for the Study of the Liver , cilt.29, sa.2, ss.227-30, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

76. Intestinal metaplasia in portal hypertensive gastropathy: A frequent pathology

Ibrisim D., Cevikbas U., Akyuz F., Poturoglu S., Ahishali E., Gulluoglu M., et al.

European Journal of Gastroenterology and Hepatology , cilt.20, sa.9, ss.874-880, 2008 (SCI-Expanded)

77. Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey

Cakaloglu Y., Akyuez F., Bozaci M., Ibrisim D., Pinarbasi B., Demir K., et al.

Turkish Journal of Gastroenterology , cilt.19, sa.2, ss.104-108, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

78. Rapidly progressive HCV cirrhosis in a hypogammaglobulinemic patient

Ermis F., Akyuez F., Demir K., Besisik F., Boztas G., Mungan Z.

Internal Medicine , cilt.47, sa.5, ss.415-417, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

79. MEFV gene mutations and inflammatory bowel disease: Is there any effect?

AKYÜZ F., Besisik F., Pinarbasi B., DEMİR K., KAYMAKOĞLU S., Ozdil S., et al.

GASTROENTEROLOGY , cilt.134, sa.4, 2008 (SCI-Expanded)

80. Peptic ulcer disease: What did change in Turkey?

Yazici A., AKYÜZ F., İŞSEVER H., Pinarbasi B., DEMİR K., Ozdil S., et al.

GASTROENTEROLOGY , cilt.134, sa.4, 2008 (SCI-Expanded)

81. The effects of rosiglitazone, metformin, and diet with exercise in nonalcoholic fatty liver disease

Akyuez F., Demir K., Oezdil S., Aksoy N., Poturoglu S., Ibrisim D., et al.

Digestive Diseases and Sciences , cilt.52, sa.9, ss.2359-2367, 2007 (SCI-Expanded)

82. What is the reason of elevated alanine aminotransferase level in HBeAg negative patients with low viremia: NAFLD or chronic hepatitis?

Demir K., Akyuz F., Ozdil S., Aksoy N., Kaymakoglu S., Poturoglu S., et al.

Annals of Hepatology , cilt.6, sa.2, ss.92-96, 2007 (Scopus) Sürdürülebilir Kalkınma

83. Long-term results of interferon alpha monotherapy in patients with HBeAg-negative chronic hepatitis B

Kaymakoglu S., Danalioglu A., Demir K., Karaca C., Akyuz F., Onel D., et al.

Digestive Diseases and Sciences , cilt.52, sa.3, ss.727-731, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

84. Lamivudine monotherapy and lamivudine plus interferon alpha combination therapy in HBeAg negative chronic hepatitis B not responding to previous interferon alpha monotherapy

Akyuz F., Kaymakoglu S., Demir K., Aksoy N., Karaca C., Danalioglu A., et al.

Acta Gastro-Enterologica Belgica , cilt.70, sa.1, ss.20-24, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

85. Pharmacoeconomic comparison of Helicobacter pylori eradication regimens

Sancar M., Izzettin F. V., Apikoglu-Rabus S., Besisik F., Tozun N., Dulger G.

Pharmacy World and Science , cilt.28, sa.4, ss.207-214, 2006 (SCI-Expanded)

86. Treatment of hepatic hydrothorax with terlipressin in a cirrhotic patient

Ibrisim D., Cakaloglu Y., Akyuz F., Karadag A., Ozdil S., Besisik F., et al.

Scandinavian Journal of Gastroenterology , cilt.41, sa.7, ss.862-865, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma

87. Neutrocytic ascites in noncirrhotic portal hypertension.

Akyüz F., Ibrişim D., Tufan F., Beşişik F., Ökten A.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.17, sa.2, ss.155-6, 2006 (Scopus)

88. Intrahepatic and peripheral T-cell responses in genotype 1b hepatitis C virus-infected patients with persistently normal and elevated aminotransferase levels

Akyuz F., Polat N., Kaymakoglu S., Aksoy N., Demir K., Besisik F., et al.

World Journal of Gastroenterology , cilt.11, sa.45, ss.7188-7191, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

89. Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacter pylori eradication

Duman D., Bor S., Ozutemiz O., Sahin T., Oguz D., Isitan F., et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.17, sa.12, ss.1357-1361, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

90. Time-related changes in the incidence, severity, and clinical outcome of hepatic veno-occlusive disease in hematopoietic stem cell transplantation patients during the past 10 years

Kalayoglu-Besisik S., Yenerel M. N., Caliskan Y., Ozturk S., Besisik F., Sargin D.

TRANSPLANTATION PROCEEDINGS , cilt.37, sa.5, ss.2285-2289, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

91. Sexual transmission of HCV between spouses

Tahan V., Karaca C., Yildirim B., Bozbaş A., Ozaras R., Demir K., et al.

American Journal of Gastroenterology , cilt.100, sa.4, ss.821-824, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

92. Alpha interferon and ribavirin combination therapy of chronic hepatitis D

Kaymakoglu S., Karaca C., Demir K., Poturoglu S., Danalioglu A., Badur S., et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , cilt.49, sa.3, ss.1135-1138, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

93. Pneumatic balloon dilatation in primary achalasia: The long-term follow-up results

Boztas G., Mungan Z., Ozdil S., Akyuz F., Karaca C., Kaymakoglu K., et al.

HEPATO-GASTROENTEROLOGY , cilt.52, sa.62, ss.475-480, 2005 (SCI-Expanded)

94. Ribavirin treatment in patients with chronic hepatitis C infection who had renal transplantation

Karaca C., Besisik F., Akyuz F., Dincer D., Sever M., Okten A.

DIGESTIVE SURGERY , cilt.22, ss.113, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

95. Ulcerative colitis: Analyses of 116 cases (do extraintestinal manifestations effect the time to catch remission?)

Ozdil S., Akyuz F., Pinarbasi B., Demir K., Karaca C., Boztas G., et al.

HEPATO-GASTROENTEROLOGY , cilt.51, sa.57, ss.768-770, 2004 (SCI-Expanded)

96. Budd-Chiari syndrome in a young patient with Celiac sprue: A case report

Danalioǧlu A., Poturoǧlu Ş., Güngör Güllüoǧlu M., Demir K., Beşişik F., Çakaloǧlu Y., et al.

Turkish Journal of Gastroenterology , cilt.14, sa.4, ss.262-265, 2003 (SCI-Expanded)

97. Crohn's disease; analysis of 105 patients.

Ozdil S., Demir K., Boztas G., Danalioglu A., Karaca C., Akyüz F., et al.

Hepato-gastroenterology , 2003 (SCI-Expanded)

98. Terlipressin and albumin combination treatment in hepatorenal syndrome.

Danalioglu A., Cakaloglu Y., Karaca C., Aksoy N., Akyuz F., Ozdil S., et al.

Hepato-gastroenterology , 2003 (SCI-Expanded)

99. Adrenomedullin in cirrhotic and non-cirrhotic portal hypertension

TAHAN V., AVŞAR E., KARACA C., Uslu E., EREN F., Aydin S., et al.

WORLD JOURNAL OF GASTROENTEROLOGY , cilt.9, sa.10, ss.2325-2327, 2003 (SCI-Expanded)

100. Clinical outcome of Crohn's disease treated with infliximab

Arslan S., Kav T., Besisik F., Kaymakoglu S., Pinarbasi B., Tozun N., et al.

HEPATO-GASTROENTEROLOGY , cilt.50, sa.52, ss.952-956, 2003 (SCI-Expanded)

101. Efficacy of cyclosporin in severe ulcerative colitis attack

Danalioglu A., Kaymakoglu S., Mungan Z., Karaca C., Demir K., Durakogk Z., et al.

International Journal of Medicine , cilt.5, sa.3, ss.194-197, 2003 (Scopus)

102. Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection

Besisik F., Karaca Q., Akyuz F., Horosanli S., Onel D., Badur S., et al.

JOURNAL OF HEPATOLOGY , cilt.38, sa.4, ss.506-510, 2003 (SCI-Expanded) Sürdürülebilir Kalkınma

103. Hepatopulmonary syndrome in noncirrhotic portal hypertensive patients

Kaymakoglu S., Kahraman T., Kudat H., Demir K., Cakaloglu Y., Adalet I., et al.

Digestive Diseases and Sciences , cilt.48, sa.3, ss.556-560, 2003 (SCI-Expanded)

104. Cyclosporin for severe ulcerative colitis attacks.

Danalioglu A., Kaymakoglu S., Mungan Z., Karaca C., Demir K., Durakoglu Z., et al.

Hepato-gastroenterology , 2003 (SCI-Expanded)

105. Alverine induced toxic hepatitis: A case report

Durakoǧlu Z., Boztaş G., Sezgil A., Kaymakoģlu S., Dinçer D., Özdil S., et al.

Turkish Journal of Gastroenterology , cilt.13, sa.4, ss.226-228, 2002 (SCI-Expanded) Sürdürülebilir Kalkınma

106. Intestinal metaplasia of the gastric cardia: A study from Turkey

Dincer D., Besisik F., Sahin E., Demir K., Tuncer I., Cevikbas U., et al.

HEPATO-GASTROENTEROLOGY , cilt.49, sa.46, ss.1153-1156, 2002 (SCI-Expanded) Sürdürülebilir Kalkınma

107. Helicobacter pylori eradication lowers esophageal sphincter pressures in functional dyspepsia patients

Besisik F., Surucu F., Mungan Z., Dincer D., Kapran Y., Kaymakoglu S., et al.

HEPATO-GASTROENTEROLOGY , sa.42, ss.1772-1775, 2001 (SCI-Expanded) Sürdürülebilir Kalkınma

108. Long-term results of alpha interferon therapy in anti-HBe(+) chronic hepatitis B.

Kaymakoglu S., Demir K., Cakaloglu Y., Durakoglu Z., Karaca C., Danalioglu A., et al.

HEPATOLOGY , cilt.34, sa.4, 2001 (SCI-Expanded) Sürdürülebilir Kalkınma

109. Solitary pancreatic tuberculosis in immunocompetent patients mimicking pancreatic carcinoma

Demir K., Kaymakoglu S., Besisik F., Durakoglu Z., Ozdil S., Kaplan Y., et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY , cilt.16, sa.9, ss.1071-1074, 2001 (SCI-Expanded) Sürdürülebilir Kalkınma

110. Persistently normal alanine transaminase levels in chronic C hepatitis: What does it tell us?

Dincer D., Okten A., Kaymakoglu S., Besisik F., Demir K., Tuncer I., et al.

HEPATO-GASTROENTEROLOGY , cilt.48, sa.41, ss.1397-1400, 2001 (SCI-Expanded) Sürdürülebilir Kalkınma

111. Tuberculous peritonitis - reports of 26 cases, detailing diagnostic and therapeutic problems

Demir K., Okten A., Kaymakoglu S., Dincer D., Besisik F., Cevikbas U., et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.13, sa.5, ss.581-585, 2001 (SCI-Expanded)

112. Lamivudine and alpha interferon combination therapy in patients with anti-HBe-positive chronic hepatitis B: Preliminary results of a randomised study

Kaymakoglu S., Demir K., Cakaloglu Y., Durakoglu Z., Dincer D., Karaca C., et al.

JOURNAL OF HEPATOLOGY , cilt.34, ss.171, 2001 (SCI-Expanded) Sürdürülebilir Kalkınma

113. Interferon alpha-2b plus ribavirin for chronic hepatitis C in primary nonresponders to interferon alone

Demir K., Kaymakoglu S., Dincer D., Tuncer I., Durakoglu Z., Karaca C., et al.

JOURNAL OF HEPATOLOGY , cilt.34, ss.171, 2001 (SCI-Expanded) Sürdürülebilir Kalkınma

114. Ascitic fluid cholesterol level in the diagnosis of postsinusoidal portal hypertension

Demir K., Kaymakoglu S., Ozdil S., Dincer D., Durakoglu Z., Karaca C., et al.

JOURNAL OF HEPATOLOGY , cilt.34, ss.230, 2001 (SCI-Expanded)

115. Genes of major histocompatibility complex class II influence chronic C hepatitis treatment with interferon in hemodialysis patients

Dincer D., Besisik F., Oguz F., Sever M., Kaymakoglu S., Cakaloglu Y., et al.

INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS , cilt.24, sa.4, ss.212-214, 2001 (SCI-Expanded) Sürdürülebilir Kalkınma

116. Miconazole induced acute hepatitis and sexual intercourse!

Beşişik F., Dinçer D., DEMİR K., KAYMAKOĞLU S., Çakalǒglu Y., Çevikbaş U., et al.

Turkish Journal of Gastroenterology , cilt.12, sa.1, ss.59-63, 2001 (SCI-Expanded) Sürdürülebilir Kalkınma

117. Serial measurements of serum transaminases in renal transplant recipients with chronic hepatitis C: do they reflect disease severity?

Besisik F., Sever M., Dincer D., Cevikbas U., Turkoglu S., Cakaloglu Y., et al.

CLINICAL TRANSPLANTATION , cilt.14, sa.6, ss.529-532, 2000 (SCI-Expanded) Sürdürülebilir Kalkınma

118. Re-bleeding in patients following Helicobacter pylori eradication therapy for bleeding peptic ulcer: Results of 18 month-follow up

Erdem L., Yildirim S., Sungun A., Besisik F.

Turkish Journal of Gastroenterology , cilt.11, sa.3, ss.212-215, 2000 (SCI-Expanded)

119. A rare complication of endoscopic injection sclerotherapy: Thrombosis of subclavian vein

Gurel S., Demir K., Kaymakoglu S., Boztas G., Cakaloglu Y., Besisik F., et al.

Hepato-Gastroenterology , cilt.47, sa.35, ss.1319-1321, 2000 (SCI-Expanded)

120. The prevalence of manifest and latent gluten sensitive enteropathy in insulin dependent diabetes mellitus.

Guvenc S., Kaymakoglu S., Polat N., Karsidag K., Demire K., Dincer D., et al.

GASTROENTEROLOGY , cilt.118, sa.4, 2000 (SCI-Expanded) Sürdürülebilir Kalkınma

121. What are the responsible factors of the development of diabetes mellitus in chronic liver disease?

Kaymakoglu S., Durakoglu Z., Demir K., Cakaloglu Y., Satman I., Karsidag K., et al.

JOURNAL OF HEPATOLOGY , cilt.32, ss.126, 2000 (SCI-Expanded) Sürdürülebilir Kalkınma

122. Idiopathic portal hypertension: Evaluation of 87 cases Idyopatik portal hipertansiyon: 87 Olgunun degerlendirilmesi

Ozturk S., Okten A., Kaymakoglu S., Cakaloglu Y., Besisik F., Mungan Z., et al.

Turkish Journal of Gastroenterology , cilt.10, sa.4, ss.334-339, 1999 (SCI-Expanded)

123. Helicobacter pylori antibodies in hemodialysis patients and renal transplant recipients

Yildiz A., Besisik F., Akkaya V., Sever M., Bozfakioglu S., Yilmaz G., et al.

CLINICAL TRANSPLANTATION , cilt.13, sa.1, ss.13-16, 1999 (SCI-Expanded)

124. Tuberculosis after renal transplantation: experience of one Turkish centre

Yildiz A., Sever M., Turkmen A., Ecder T., Besisik F., Tabak L., et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.13, sa.7, ss.1872-1875, 1998 (SCI-Expanded) Sürdürülebilir Kalkınma

125. Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis?

Kaymakoglu S., Cakaloglu Y., Demir K., Turkoglu S., Badur S., Gurel S., et al.

JOURNAL OF HEPATOLOGY , cilt.28, sa.1, ss.78-83, 1998 (SCI-Expanded) Sürdürülebilir Kalkınma

126. Central and nonsplanchnic hemodynamic changes in liver cirrhosis Karacijer sirozunda santral ve nonsplanknik hemodinamik degisiklikler

Dincer D., Besisik F., Demirkol O., Demir K., Kaymakoglu S., Cakaloglu Y., et al.

Turkish Journal of Gastroenterology , cilt.9, sa.1, ss.14-20, 1998 (SCI-Expanded)

127. Demographic, clinic and etiologic features of the patients with rectal bleeding Rektal kanamali hastalarimizda demografik, klinik ve etyolojik ozellikler

Furuncuoglu Y., Mungan Z., Yeginsu O., Cakaloglu Y., Boztas G., Kaymakoglu S., et al.

Turkish Journal of Gastroenterology , cilt.9, sa.3, ss.279-283, 1998 (SCI-Expanded)

128. Etiologies of chronic hepatitis Kronik hepatitlerin etyolojik dagilimi

Okten A., Demir K., Kaymakoglu S., Cakaloglu Y., Dincer D., Besisik F.

Turkish Journal of Gastroenterology , cilt.9, sa.2, ss.113-115, 1998 (SCI-Expanded) Sürdürülebilir Kalkınma

129. Recurrence rates after Helicobacter pylori eradication Helicobacter pylori eradikasyonu sonrasinda nuks oranlari

Gurel S., Besisik F., Demir K., Mungan Z., Kaymakoglu S., Boztas G., et al.

Turkish Journal of Gastroenterology , cilt.9, sa.2, ss.154-158, 1998 (SCI-Expanded)

130. Relationship between serum levels of interleukin-10 (IL-10), interleukin-2 (IL-2) and soluble intercellular adhesion molecule-1 (sICAM-1) and liver injury in chronic hepatitis B virus infection

Kaymakoglu S., Gurel N., Demir K., Cakaloglu Y., Badur S., Besisik F., et al.

HEPATOLOGY , cilt.26, sa.4, ss.768, 1997 (SCI-Expanded) Sürdürülebilir Kalkınma

131. Helicobacter pylori infection: An important determinant of blood ammonia level in healthy persons and in cirrhotics

Cakaloglu Y., Saban K., Demir K., Mungan Z., Kaymakoglu S., Besisik F., et al.

GUT , cilt.41, 1997 (SCI-Expanded)

132. Response to hepatitis B vaccine in patients with non-hepatitis B chronic liver disease Hepatit B disi etyolojili kronik karaciger hastaliklarinda hepatit B asisina immun cevap

Agan A., Cakaloglu Y., Okten A., Badur S., Erdem L., Gurel S., et al.

Turkish Journal of Gastroenterology , cilt.8, sa.2, ss.148-151, 1997 (SCI-Expanded) Sürdürülebilir Kalkınma

133. Spontaneous ascitic infection in different cirrhotic groups: Prevalence, risk factors and the efficacy of cefotaxime therapy

Kaymakoglu S., Eraksoy H., Okten A., Demir K., Calangu S., Cakaloglu Y., et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.9, sa.1, ss.71-76, 1997 (SCI-Expanded)

134. Assessment by color Doppler sonography of the hepatic and splenic arteries blood flow in patients with liver cirrhosis Karaciger sirozlu hastalarda hepatik ve splenik arter akimlarinin renkli Doppler sonografi ile degerlendirilmesi

Gurel S., Demir K., Faradzade H., Kaymakoglu S., Cakaloglu Y., Besisik F., et al.

Turkish Journal of Gastroenterology , cilt.8, sa.2, ss.152-155, 1997 (SCI-Expanded)

135. Wear gloves to protect not only your hands but also your stomach during upper GI procedures!

BEŞIŞIK S. F.

Marmara Medical Journal , cilt.10, sa.1, ss.52-53, 1997 (Scopus)

136. HYPOGONADISM IS NOT RELATED TO THE ETIOLOGY OF LIVER-CIRRHOSIS

KAYMAKOGLU S., OKTEN A., CAKALOGLU Y., BOZTAS G., BESISIK F., TASCIOGLU C., et al.

JOURNAL OF GASTROENTEROLOGY , cilt.30, sa.6, ss.745-750, 1995 (SCI-Expanded) Sürdürülebilir Kalkınma

137. The effect of pyridoxal hydrochloride on serum aminotransferase levels of uremic hemodialysis patients HEMODIYALIZ HASTALARINDA PIRIDOKSIN HIDROKLORUR KULLANIMININ SERUM ASPARTAT AMINOTRANSFERAZ DUZEYI UZERINE OLAN ETKISI (UREMI VE B6 VITAMIN ETKILESIMI)

Demir K., Aysuna N., Besisik F., Azezli A., Sever M., Ozdogan E.

Istanbul Tip Fakultesi Mecmuasi , cilt.58, sa.2, ss.28-30, 1995 (Scopus)

138. A case of antiphospholipid antibody syndrome BIR ANTIFOSFOLIPID ANTIKORU SENDROMU VAKASI

Tascioglu C., Karan M., Ates A., Besisik F., Guler K., Erten N., et al.

Istanbul Tip Fakultesi Mecmuasi , cilt.58, sa.4, ss.120-123, 1995 (Scopus)

139. Effect of omeprazole plus ciprofloxacin on healing of duodenal ulcer and clearance of Helicobacter pylori

Sezer R., Kaymakoglu S., Cakaloglu Y., Boztas G., Mungan Z., Ozdil S., et al.

Medical Bulletin of Istanbul Medical Faculty , cilt.28, sa.2, ss.10-14, 1995 (Scopus)

140. A case of colon carcinoma associated with paraproteinemia

Tascioglu C., Azezli A., Ates A., Besisik F., Sargin D., Kaysi A., et al.

Istanbul Tip Fakultesi Mecmuasi , cilt.57, sa.2, ss.73-75, 1994 (Scopus)

141. Gastrointestinal manifestations of HIV infection (because of two cases)

Sezer R., Boztas G., Erol N., Yeginsu O., Ulasoglu C., Kaymakoglu S., et al.

Istanbul Tip Fakultesi Mecmuasi , cilt.57, sa.2, ss.51-55, 1994 (Scopus) Sürdürülebilir Kalkınma

142. The place of L-thyroxine treatment in the prevention of recurrence following subtotal thyroidectomy performed for nontoxic goiter

Besisik F., Molvalilar S., Kalayoglu S., Tascioglu C., Gencer E., Acar A., et al.

Klinik Gelisim , cilt.6, sa.3, ss.2317-2320, 1993 (Scopus)

143. Liver cirrhosis and coagulation

Tascioglu C., Azezli A., Besisik F., Guler K., Keskin H., Ecder T., et al.

Istanbul Tip Fakultesi Mecmuasi , cilt.56, sa.3, ss.13-17, 1993 (SCI-Expanded)

144. Sağlık personeli olmak HCV infeksiyonu açısından risk faktörü mü ? Asemptomatik sağlık personelinde HCV seroprevalansı.

Beşışık F., Ökten A., Kaymakoğlu S., BADUR O. S., Yalçın S., AĞAÇFİDAN A.

Gastroenterohepatoloji , cilt.3, sa.3, ss.169-171, 1992 (Hakemli Dergi)

145. HORIZONTAL TRANSMISSION OF HEPATITIS-B VIRUS-INFECTION

CAKALOGLU Y., KAYMAKOGLU S., OKTEN A., BESISIK F., BADUR S., YALCIN S.

JOURNAL OF HEPATOLOGY , cilt.15, ss.265-266, 1992 (SCI-Expanded) Sürdürülebilir Kalkınma

146. Clinical and laboratory findings in idiopathic and surgical hypoparathyroidism

Tanakol R., Alagol F., Azizlerli H., Besisik F., Terzioglu T., Tezelman S., et al.

Istanbul Tip Fakultesi Mecmuasi , cilt.54, sa.1, ss.15-22, 1991 (Scopus)

147. Surgical treatment of active infective endocarditis resistant to medical treatment

Besisik F., Adalet K., Nisanci Y., Barlas C., Onursal E., Yagan N., et al.

Istanbul Tip Fakultesi Mecmuasi , cilt.53, sa.4, ss.121-129, 1990 (Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 54

1. 10-year results under tenofovir disoproxil fumarate and entecavir in chronic hepatitis B; HBV clearance rare, disease outcomes good

İstemihan Z., Kemeç G., Cebeci T., Çetin O., Genç Uluçeçen S., Rüstemzade A., et al.

EASL Congress 2024, Milan, İtalya, 5 - 08 Haziran 2024, ss.803, (Özet Bildiri)

2. The relationship between spleen stiffness and portal hypertension liver transplant patients

Nurıyev K., İstemihan Z., Telli P., Qurbanov A., Yağlı M. A., Dağcı G., et al.

EASL Congress 2024, Milan, İtalya, 5 - 08 Haziran 2024, ss.377-378, (Özet Bildiri)

3. Steatotic liver disease in diabetic patients: more serious diabetes mellitus, more serious liver disease

İstemihan Z., Bektaş F., Bardak A. E., Kızıltaş C., Kemeç G., Nurıyev K., et al.

EASL Congress 2024, Milan, İtalya, 5 - 08 Haziran 2024, ss.551, (Özet Bildiri)

4. Clinical characteristics of patients with hereditary hemorrhagic telangiectasia: Real-life data, single-center experience

İstemihan Z., Bardak A. E., Nurıyev K., Rüstemzade A., Genç Uluçeçen S., Çavuş B., et al.

ESGE Days 2024, Berlin, Almanya, 25 - 27 Nisan 2024, ss.297, (Özet Bildiri)

5. Spontan İntrahepatik Portosistemik Venöz Şant Olgusu

Karaca D., Çavuş B., Poyanlı A., Beşışık S. F.

25. Ulusal İç Hastalıkları Kongresi, Antalya, Türkiye, 8 - 12 Kasım 2023, ss.670, (Tam Metin Bildiri)

6. Otoimmün Tanılı Hastalarda Viral Serolojik Profilin Değerlendirilmesi

Küçükkaya S., Çaklovica Küçükkaya İ., Çavuş B., Safran N., Önel M., Kırkoyun Uysal H., et al.

7. Ulusak Klinik Mikrobiyoloji Kongresi (KLİMUD), Muğla, Türkiye, 1 - 05 Kasım 2023, ss.635, (Özet Bildiri)

7. HYPERLIPIDEMIA, ATHEROSCLEROSIS AND HEPATOSTEATOSIS IN PRIMARY BILIARY CHOLANGITIS: WHAT IS THE RISK?

ÇOŞKUN A., Ormeci A. C., ÇAVUŞ B., ŞENKAL İ. V., KARAPINAR E., POYANLI A., et al.

Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 10 - 14 Kasım 2023, (Özet Bildiri)

8. Evaluatıon Of The Effıcacy And Complıcatıons Of Plasma Exchange In Anca- Assocıated Vasculıtıs: Results Of Propensıty Score Matchıng Analysıs In Hıgh-Rısk Patıents

İNCE B., BEKTAŞ M., ÇELİK B., YÜCE S., YALÇINKAYA Y., ARTIM ESEN B., et al.

ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY 2023, 31 Mayıs - 03 Haziran 2023, (Özet Bildiri)

9. ARE THERE NEW PRACTICAL MARKERS TO PREDICT MALIGNANCY IN PANCREATIC CYST FLUIDS?

Anıl K. U., Çavuş B., Çifcibaşı Örmeci A., İmanov Z., Şenkal İ. V., Nurıyev K., et al.

Digestive Disease Week 2023, Washington, Amerika Birleşik Devletleri, 6 - 09 Mayıs 2023, ss.774, (Özet Bildiri)

10. Tedavi naif ve deneyimli Kronik Hepatit B hastalarında tenofovir alafenamidin gerçek yaşam verileri: daha fazla etki, daha az yan etki

Bektaş E., Yılmaz A., Kıkılı C. İ., Nurıyev K., İstemihan Z., Şenkal İ. V., et al.

39. Ulusal Gastroenteroloji Haftası ve 10. Gastroenteroloji Cerrahisi Kongresi, Antalya, Türkiye, 22 - 27 Kasım 2022, ss.1159-1162, (Özet Bildiri)

11. SENKRON İNTERSTİSYEL AKCİĞER HASTALIĞI, KARACİĞER SİROZU VE HİPOSELLÜLER KEMİK İLİĞİ: TELOMEROPATİLERE BİR İPUCU

ZARALI S., ALTINKAYNAK M., AKPINAR T. S., GÖKSOY SOLAK Y., ERTEN S. N., SAKA B., et al.

24. Ulusal İç Hastalıkları Kongresi, Antalya, Türkiye, 19 - 23 Ekim 2022, ss.170, (Tam Metin Bildiri)

12. GASTROİNTESTİNAL KANAMA İLE BAŞVURAN RENAL HÜCRELİ KARSİNOM OLGUSU

Aydın M. H., Beşışık S. F., Çavuş B., İribaş Çelik A.

24. ULUSAL KANSER KONGRESİ, İstanbul, Türkiye, 9 - 13 Kasım 2022, ss.1-2, (Özet Bildiri)

13. HEMOFAGOSİTİK LENFOHİSTİYOSİTOZUN NADİR BİR SEBEBİ: VİSSERAL LEİSHMANİASİS

Yılmaz A., Bektaş E., Bilgin E., Şenkal İ. V., Çavuş B., Çifcibaşı Örmeci A., et al.

24. Ulusal İç Hastalıkları Kongresi, Antalya, Türkiye, 19 - 23 Ekim 2022, ss.118-119, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

14. REAL-WORLD DATA OF TENOFOVIR ALAFENAMIDE IN TREATMENT-NAIVE AND EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS B: MORE EFFICACY, LESS SIDE EFFECTS

Bektaş E., Yılmaz A., Kıkılı C. İ., Nurıyev K., İstemihan Z., Şenkal İ. V., et al.

AASLD Liver Meeting , District Of Columbia, Amerika Birleşik Devletleri, 4 - 08 Kasım 2022, cilt.76, ss.299, (Özet Bildiri)

15. İshal ve kilo kaybının nadir bir nedeni:Amiloidoz

Çiftçi A. C., Konyaoğlu H., Şenkal İ. V., Çavuş B., Çifcibaşı Örmeci A., Akyüz F., et al.

21. Çapa Gastroenteroloji Günleri, İstanbul, Türkiye, 31 Mart - 02 Nisan 2022, ss.70, (Tam Metin Bildiri)

16. Ön Segment Optik Koherans Tomografi (OCT), Wilson hastalığı tanısında Kayser Fleischer Halkası varlığını değerlendirmeki yeri - Ehil oftalmolog gerekliliğine son verecek mi?

Çifcibaşı Örmeci A., Bayraktar Ş., Işık A. O., İstemihan Z., Sarıdal M. K., Akas R., et al.

38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Türkiye, 16 - 21 Kasım 2021, ss.218, (Özet Bildiri)

17. Budd-Chiari Sendromu’nda Hepatoselüler Kanser ve Mortalitenin Değerlendirilmesi

İstemihan Z., Nurıyev K., Şenkal İ. V., İmanov Z., Sarıdal M. K., Akas R., et al.

38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Türkiye, 16 - 21 Kasım 2021, ss.219, (Özet Bildiri) Sürdürülebilir Kalkınma

18. Renal transplant alıcılarında AA amiloidoz nüksünü saptamada non-invazif bir yöntem olarak transient elastografi (fibroscan)

Bektaş M., Dirim A. B., Çavuş B., Sarı S., Şenkal İ. V., Ağargün B. F., et al.

Romatolojide Hedef 2021, İstanbul, Türkiye, 27 - 30 Ekim 2021, ss.1-2, (Özet Bildiri)

19. Transient Elastography (fi broscan); As a New Non-invasiveDiagnostic Method for Detecting Hepatic Involvement ofAmyloidosis

Bektaş M., Çavuş B., Ağargün B. F., Şenkal İ. V., Koca N., İnce B., et al.

ACR, Arizona, Amerika Birleşik Devletleri, 5 - 09 Kasım 2021, cilt.10, sa.73, ss.1-4, (Özet Bildiri)

20. Transient Elastography (Fibroscan) as a Non-InvasiveMethod for Detecting Amyloid Deposition in TransplantedKidneys in Patients with AA Amyloidosis

Bektaş M., Çavuş B., Dirim A. B., Sarı S., Şenkal İ. V., Koca N., et al.

ACR, Arizona, Amerika Birleşik Devletleri, 5 - 09 Kasım 2021, cilt.10, sa.73, ss.1-5, (Özet Bildiri)

21. TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B: WHAT ARE THE TRIGGERS OF DRUG-RELATED ADVERSE EFFECTS?

Kapar C., Cavus B., Atasoy A., Suleymanova V., Isik A., Karahan L., et al.

Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), ELECTR NETWORK, 13 - 16 Kasım 2020, cilt.72, (Özet Bildiri) Sürdürülebilir Kalkınma

22. Is belching increasing after bariatric by-pass surgery in the long term period?

AKYÜZ F., GÖKSOY B., TELLİ P., NİZAM N., ATASOY A., ÇAVUŞ B., et al.

United European Gastroenterology (UEG) Week 2019, İspanya, 19 - 23 Ekim 2019, cilt.7, ss.703, (Özet Bildiri)

23. Bone health in liver transplant recipients: Corticosteroids preserve their significance, what about late follow-up?

MİRİOĞLU Ş., ÇAKMAK DEMİR S., ILIAZ R., ÇELEN ÖGÜNÇ H., AKYÜZ F., DEMİR K., et al.

AASLD-TASL Connect Regional Meeting, İstanbul, Türkiye, 15 - 16 Mart 2019, cilt.30, ss.21-22, (Tam Metin Bildiri)

24. Bone health in liver transplant recipients: Corticosteroids preserve their significance, what about late follow-up?

MİRİOĞLU Ş., ÇAKMAK DEMİR S., ILIAZ R., ÇELEN ÖĞÜNÇ H., AKYÜZ F., DEMİR K., et al.

AASLD-TASL Connect Regional Meeting, İstanbul, Türkiye, 15 - 16 Mart 2019, cilt.30, ss.21-22, (Özet Bildiri)

25. Tens asitli siroz hastalarında intraabdominal hipertansiyonun prognoz üzerine etkisi

MUTLU Ü., ATASOY A., ILIAZ R., ÇAVUŞ B., AKYÜZ F., DEMİR K., et al.

11. Ulusal Hepatoloji Kongresi, Antalya, Türkiye, 17 - 21 Mayıs 2017, ss.31-32, (Özet Bildiri)

26. Vitamin D receptor gene polymorphisms may affect the interferon response in chronic hepatitis B patients

AKYÜZ F., UÇAR A. R., ÇİFTÇİ S., KESKİN F., ILIAZ R., ÇAVUŞ B., et al.

26th Annual Conference of APASL, Shanghai, Çin, 15 - 19 Şubat 2017, cilt.11, sa.1, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

27. Kronik hepatit C’li hastalar artık daha yaşlı ve daha ciddi karaciğer hastalığı ile kliniğe başvuruyor

ILIAZ R., YÜCE İNEL T., TORUN E. S., ÇAVUŞ B., GÜLLÜOĞLU M., Bozacı M., et al.

XIII. Ulusal Viral Hepatit Kongresi, Antalya, Türkiye, 17 - 20 Mart 2016, ss.18, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

28. COMPARISON OF PROGNOSTIC SCORING SYSTEMS FOR PREDICTION OF SURVIVAL IN HEPATOCELLULAR CARCINOMA

Baran B., Ekinci O., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., et al.

EASL International Liver Congress, Barcelona, İspanya, 13 - 17 Nisan 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

29. Belching in irritable bowel syndrome: an impedance study

Akyuz F., Obekli T., Iliaz R., Arici S., Gokturk S., Karaca C., et al.

NeuroGASTRO Conference, İstanbul, Türkiye, 4 - 06 Haziran 2015, ss.38-39, (Özet Bildiri)

30. The frequency of gastro-esophageal reflux disease in patients with mild-moderate stage chronic obstructive lung disease (COPD) and its relationship with acute exacerbations of COPD

Iliaz S., Akyuz F., Onur S. T., Akyuz U., Karaca C., Demir K., et al.

NeuroGASTRO Conference, İstanbul, Türkiye, 4 - 06 Haziran 2015, ss.70, (Özet Bildiri)

31. Cyclosporine Therapy As a Rescue Treatment in Acute Severe Ulcerative Colitis: A Real Life-Data From a Tertiary Center

Evirgen S., Iliaz R., AKYÜZ F., ÇAVUŞ B., Pinarbasi B. S., Karaca C., et al.

46th Annual Digestive Disease Week (DDW), Washington, Kiribati, 16 - 19 Mayıs 2015, cilt.148, (Özet Bildiri)

32. Single disease with multisystemic symptoms: POEMS Syndrome and Novel Approach

KALAYOĞLU BEŞIŞIK S., TORUN E. S., AKPINAR T. S., TUFAN F., ARSLAN Ö., TURAN ERKEK E., et al.

40. Ulusal Hematoloji Kongresi 2014, 22 - 25 Ekim 2014, (Özet Bildiri)

33. The Course of Pregnancy in Wilson's Disease-One Center, 20 Years' Experience

DEMİR K., Soyer O. M., Karaca C., BEŞIŞIK S. F., KAYMAKOĞLU S., BEŞIŞIK S. F.

55th Annual Meeting of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / Digestive Disease Week (DDW), Illinois, Amerika Birleşik Devletleri, 3 - 06 Mayıs 2014, cilt.146, (Özet Bildiri)

34. ENTECAVIR AND TENOFOVIR HAVE A COMPARABLE EFFICACY IN TREATMENT OF NUCLEOS(T)IDE ANALOGUE NAIVE PATIENTS WITH CHRONIC HEPATITIS B: A REAL LIFE EXPERIENCE

Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.

49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver, London, Kanada, 9 - 13 Nisan 2014, (Özet Bildiri)

35. Does Chemoprophylaxis Prevent Tuberculosis Reactivation in the Long Term Period of Anti-TNF Treatment?

AKYÜZ F., Soyer O. M., Gokturk S., ÇİFCİBAŞI ÖRMECİ A., Evirgen S., Onder S. Y., et al.

Digestive Disease Week / 28th Annual Residents and Fellows Research Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT), Florida, Amerika Birleşik Devletleri, 18 - 21 Mayıs 2013, cilt.144, (Özet Bildiri)

36. TREATMENT FAILURE MAY LEAD TO ACCELERATED FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C

Baran B., Gulluoglu M., Soyer O., Ormeci A., Gokturk S., Evirgen S., et al.

International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Amsterdam, Hollanda, 24 - 28 Nisan 2013, (Özet Bildiri)

37. HBsAg CLEARENCE AFTER LONG-TERM FOLLOW-UP IN CHRONIC HEPATITIS B PATIENTS TREATED WITH INTERFERON ALPHA AND NUCLEOS(T)IDE ANALOGUES

Pinarbasi B., Kaymakoglu S., Akyuz F., Issever H., Ermis F., Uyanikoglu A., et al.

44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Copenhagen, Danimarka, 22 - 26 Nisan 2009, (Özet Bildiri)

38. Electron microscopic findings in now alcoholic fatty liver disease; Is there any difference between hepatosteatosis and steatohepatitis?

Ahishali E., Demir K., Ahishali B., Akyuz F., Pinarbasi B., Poturoglu S., et al.

43rd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Milan, İtalya, 23 - 27 Nisan 2008, cilt.48, (Özet Bildiri)

39. Low-dose peginterferon alfa-2a (40kd) (Pegasys (R)) to treat hepatitis C-infected, end-stage renal disease patients undergoing haemodialysis: Final study results

Peck-Radosavljevic M., Boletis J., Besisik F., Ferraz M. L., Alric L., Samuel D., et al.

43rd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Milan, İtalya, 23 - 27 Nisan 2008, cilt.48, (Özet Bildiri) Sürdürülebilir Kalkınma

40. The presence of HCVRNA in the peripheral blood mononuclear cells of the individuals with isolated anti HCV positivity: Is HCV hiding out?

Pinarbasi B., Bozaci M., Akyuz F., Badur S., Demir K., Besisik F., et al.

43rd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Milan, İtalya, 23 - 27 Nisan 2008, (Özet Bildiri) Sürdürülebilir Kalkınma

41. High baseline HBV-DNA is linked to the emergence of adefovir resistance in lamivudine resistant patients

Kaymakoglu S., Idilman R., Ahishali E., Onder F. O., Bektas M., Badur S., et al.

42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Barcelona, İspanya, 11 - 15 Nisan 2007, cilt.46, (Özet Bildiri)

42. Use of low-dose peginterferon alpha-2a (40kD) 628 (pegasys (R)) to treat hepatitis C-infected end-stage renal disease patients undergoing haemodialysis: Interim results from a randomised study

Peck-Radosavljevic M., Boletis J., Besisik F., Ferraz M. L., Alric L., Samuel D., et al.

42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Barcelona, İspanya, 11 - 15 Nisan 2007, cilt.46, (Özet Bildiri) Sürdürülebilir Kalkınma

43. Virological breakthrough is not a detrimental phenomenon in patients with compensated cirrhosis:: Results of a long term lamivudine therapy

Cakaloglu Y., Kaymakoglu S., Akyuz F., Ibrisim D., Demir K., Onel D., et al.

56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Kostarika, 11 - 15 Kasım 2005, (Özet Bildiri)

44. Hepatosteatosis in patients with chronic hepatitis B:: Prevalence and the effect on the treatment response rate to α-interferon

Aksoy N., Kaymakoglu S., Cevikbas U., Demir K., Akyuz F., Badur S., et al.

40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Paris, Fransa, 13 - 17 Nisan 2005, ss.241-242, (Özet Bildiri)

45. The effects of roziglitazone, metformine and diet with exercise in nonalcoholic fatty liver disease

Akyuz F., Demir K., Ozdil S., Aksoy N., Poturoglu S., Ibrisim D., et al.

39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Berlin, Almanya, 14 - 18 Nisan 2004, ss.167, (Özet Bildiri)

46. Long term results of alpha-interferon monotherapy

Kaymakoglu S., Cakaloglu Y., Danalioglu A., Demir K., Akyuz F., Aksoy N., et al.

38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Türkiye, 29 Mart - 01 Nisan 2003, ss.149, (Özet Bildiri)

47. Combined or monotherapy, which is better in AntiHBe (+) chronic hepatitis B ?

Danalioglu A., KAYMAKOĞLU S., Cakaloglu Y., DEMİR K., AKYÜZ F., Aksoy N., et al.

Digestive Disease Week 2003 Meeting/104th Annual Meeting of the American-Gastroenterological-Association, ORLANDO, FLORIDA, 17 - 22 Mayıs 2003, cilt.124, (Özet Bildiri)

48. Are ascitic fluid cholesterol and ratio of ascites/serum cholesterol able to reflect hepatic sinusoidal capillarization?

Demir K., Karaca C., Kaymakoglu S., Ozdil S., Besisik F., Boztas G., et al.

38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Türkiye, 29 Mart - 01 Nisan 2003, cilt.38, ss.57-58, (Özet Bildiri)

Kitaplar 1

1. KOMA

VATANSEVER S., TAŞCIOĞLU C., KARAN M. A., BEŞIŞIK S. F., KRESPİ Y.

ACİL DAHİLİYE, CALANGU S, GULER K, Editör, Nobel Tıp Kitabevleri Ltd. Şti., İstanbul, ss.677-694, 2009

Metrikler

Yayın

202

Yayın (WoS)

156

Yayın (Scopus)

142

Atıf (WoS)

1458

H-İndeks (WoS)

Atıf (Scopus)

1697

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler